About Made Scientific — Cell Therapy CDMO Partner

Syed T. Husain leads Made Scientific as Chairman and Chief Executive Officer, bringing deep expertise across the CDMO spectrum, from development to commercialization of both established and emerging therapeutic modalities. His strategic vision blends operational excellence with bold innovation to advance breakthrough cell therapies. 

Throughout his distinguished career, Syed has guided organizations through transformative growth and market disruption. Prior to Made Scientific, as Chief Commercial Officer at Resilience, he built a world-class commercial organization spanning cell and gene therapies, biologics, vaccines, and nucleic acids, establishing a multi-billion-dollar opportunity pipeline through strategic partnerships. His leadership roles at Emergent BioSolutions, Alcami Corporation, and Lonza sharpened his expertise in commercial strategy and operations. Syed began his career in manufacturing compliance at Wyeth before advancing through validation, product development, and manufacturing leadership positions at Pfizer. 

Syed holds a Master of Business Administration from Cornell University's Johnson Graduate School of Management and a Bachelor of Science in Chemical Engineering from the New Jersey Institute of Technology, where he serves on the Industrial Advisory Board for the Otto H York Department of Chemical Engineering. His industry leadership includes chairing the Education Committee and serving on the Advisory Council for the Drug, Chemical & Associated Technologies Association, alongside active involvement in the Biotechnology Innovation Organization, Society of Biological Engineers, American Institute of Chemical Engineers, and American Chemical Society. Syed’s leadership is driven by bold innovation and challenging industry norms to create a CDMO model that accelerates scalability, enhances flexibility, and ensures manufacturing readiness for groundbreaking therapies.

Jill Gliem serves as Vice President and Head of Technical Operations at Made Scientific, bringing more than 20 years of experience across biopharmaceutical manufacturing and operations. She specializes in leading GMP manufacturing organizations with a focus on operational excellence, regulatory readiness, and scalable execution across complex manufacturing environments.

Most recently, Jill served in senior manufacturing and site leadership roles within the cell therapy CDMO space, where she oversaw daily operations, cross-functional teams, and the execution of advanced manufacturing programs. Earlier in her career, she spent nearly 16 years at Merck in progressively senior leadership roles supporting large-scale commercial vaccine manufacturing, barrier operations, and technical services, building deep expertise in GMP operations and inspection readiness.

Jill holds a Bachelor’s degree in Chemical Engineering from Lehigh University and leads technical operations with a strong emphasis on GMP rigor, manufacturing performance, and operational stability, ensuring programs are executed with precision, reliability, and patient impact in mind.

Irving Ford serves as Vice President and Head of Quality at Made Scientific, bringing more than 30 years of experience guiding global pharmaceutical and biotechnology organizations through complex regulatory milestones. His leadership centers on inspection readiness, external manufacturing oversight, and strengthening quality organizations to support commercial execution of advanced therapies.

Most recently, as Vice President of Quality at Adaptimmune, Irving led Quality oversight supporting the Biologics License Application (BLA) submission for TECELRA® and directed Pre-License Inspection (PLI) readiness across internal operations and Contract Manufacturing Organizations. He previously held senior quality leadership roles at Bristol Myers Squibb and Novartis, contributing to regulatory activities supporting the approvals of ABECMA®, BREYANZI®, and KYMRIAH® and helping organizations navigate high-stakes regulatory interactions.

Irving contributes to industry advancement through his work with the Parenteral Drug Association, where he serves on the PDA ATMP Advisory Board and supports technical guidance shaping cell and gene therapy manufacturing. He holds a Master of Science and Bachelor of Science in Biology with an emphasis in Microbiology from Alabama State University and is known for bringing clarity, stability, and regulatory confidence to organizations operating at the forefront of therapy innovation.

David Smith, Ph.D., leads Development at Made Scientific, overseeing Manufacturing Science & Technology (MS&T), Process Development, and Analytical Method Development with the insight that comes from 15+ years of regenerative medicine and cell therapy manufacturing experience. 

Prior to joining Made Scientific, David served as Vice President of Technical Operations at Ori Biotech, where he crafted strategies that shaped Ori's pioneering cell therapy manufacturing technology platform. His leadership at Minaris Regenerative Medicine produced process innovations that continue to influence the field today. David's commitment to advancing industry standards is evident through his active leadership roles within organizations including ISCT, ARM, ISO, ASME, and PDA. 

With a Ph.D. in Regenerative Medicine from Loughborough University, David combines scientific rigor with practical manufacturing expertise. He champions quality-by-design principles and data-driven approaches that transform promising therapies into reproducible manufacturing processes—ultimately connecting breakthrough science with patient care.

Joe Sinclair directs commercial strategy and client partnerships as Vice President and Head of Commercial at Made Scientific, bringing over 15 years of experience in scaling CDMO operations for advanced therapeutics. 

Before joining Made Scientific, Joe served as Senior Vice President of US Operations and GMP Site Head at uBriGene Biosciences, where he successfully launched cell therapy manufacturing solutions that addressed critical market needs. His strategic leadership roles at Recipharm/Vibalogics, WuXi Advanced Therapies, and WuXi AppTec have equipped him with valuable insights into building lasting client relationships founded on transparency and collaboration. 

Joe holds a Bachelor of Science in Business Administration with a concentration in Pharmaceutical and Healthcare Marketing from Saint Joseph's University. He approaches each client partnership with the understanding that behind every manufacturing project lies the potential to transform patient lives.

As Vice President and Head of Human Resources at Made Scientific, Ria S. Barrett leads people-centered strategies that enable our technical excellence. Her 15+ years of HR leadership across life sciences, legal, and professional services sectors inform her holistic approach to talent management and organizational development. 

Most recently at Lantheus Medical Imaging, Ria implemented talent frameworks that supported business growth while fostering an inclusive workplace culture. She recognizes that behind every manufacturing success is a team of dedicated professionals whose expertise and commitment drive innovation. 

Ria holds an MBA in Human Resources from Nyack College and a Bachelor of Arts in Business Administration with a concentration in HR Management from Adelphi University. She believes that cultivating an environment where scientific talent can thrive is essential to delivering on Made Scientific's promise to clients and, ultimately, to patients. 

Michelle Ng serves as Senior Director and Head of Portfolio and Program Management at Made Scientific, bringing over 13 years of project management experience across charitable, private, and public organizations. She specializes in driving collaboration between clients and CDMOs, creating a one-team mindset that keeps programs focused on shared goals and overcomes common barriers in complex partnerships.

Prior to joining Made Scientific, Michelle held leadership roles where she developed and implemented project management processes that strengthened cross-functional collaboration across Program Management, Technical Operations, and Finance teams. Her experience spans the full development lifecycle, from early-phase and pre-clinical programs to commercial manufacturing, giving her deep insight into the operational and strategic needs of high-impact programs.

Michelle holds an Honours Bachelor of Science degree, is a certified Project Management Professional (PMP), and earned her MBA with a concentration in business strategy and strategic management. She approaches portfolio management with the belief that effective collaboration and shared focus are essential to successfully bringing innovative therapies to patients.

Byungyong (Henry) Han guides financial strategy and operational efficiency as Senior Director and Head of Finance at Made Scientific. With more than 15 years in financial management, Henry brings valuable expertise in corporate finance, M&A, and operational excellence to the company's growth initiatives. 

Prior to Made Scientific, Henry served as Financial and Accounting Team Leader at Ubcare Co. Ltd., where he managed post-merger integration following the company's $200 million acquisition by GC. His experience as Finance Team Manager at Green Cross Holdings Corporation included overseeing corporate bond issuances and governance practices that established financial stability. 

Henry holds a Bachelor's degree in Business Administration from Chung-Ang University in Seoul, Korea. He approaches financial management with the understanding that sound fiscal practices create the foundation for scientific innovation and reliable manufacturing partnerships.